Amdocs Long Term Debt vs Net Invested Capital Analysis

DOX Stock  USD 88.24  1.11  1.27%   
Amdocs financial indicator trend analysis is way more than just evaluating Amdocs prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Amdocs is a good investment. Please check the relationship between Amdocs Long Term Debt and its Net Invested Capital accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Amdocs. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.

Long Term Debt vs Net Invested Capital

Long Term Debt vs Net Invested Capital Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Amdocs Long Term Debt account and Net Invested Capital. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Amdocs' Long Term Debt and Net Invested Capital is 0.56. Overlapping area represents the amount of variation of Long Term Debt that can explain the historical movement of Net Invested Capital in the same time period over historical financial statements of Amdocs, assuming nothing else is changed. The correlation between historical values of Amdocs' Long Term Debt and Net Invested Capital is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Debt of Amdocs are associated (or correlated) with its Net Invested Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Invested Capital has no effect on the direction of Long Term Debt i.e., Amdocs' Long Term Debt and Net Invested Capital go up and down completely randomly.

Correlation Coefficient

0.56
Relationship DirectionPositive 
Relationship StrengthWeak

Long Term Debt

Long-term debt is a debt that Amdocs has held for over one year. Long-term debt appears on Amdocs balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Amdocs balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.

Net Invested Capital

The total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents.
Most indicators from Amdocs' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Amdocs current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Amdocs. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.At this time, Amdocs' Sales General And Administrative To Revenue is fairly stable compared to the past year. Enterprise Value Over EBITDA is likely to rise to 15.40 in 2024, whereas Selling General Administrative is likely to drop slightly above 390.6 M in 2024.
 2021 2022 2023 2024 (projected)
Gross Profit1.6B1.7B2.0B1.1B
Total Revenue4.6B4.9B5.6B3.1B

Amdocs fundamental ratios Correlations

0.560.510.950.960.650.20.770.050.430.970.750.440.93-0.880.650.73-0.610.940.810.040.950.640.940.530.95
0.560.50.440.490.730.530.76-0.2-0.220.680.67-0.250.67-0.760.610.85-0.770.570.150.110.620.730.630.090.47
0.510.50.370.320.840.770.77-0.43-0.040.590.750.030.37-0.710.850.71-0.820.670.19-0.330.510.840.550.550.5
0.950.440.370.970.48-0.010.690.30.480.880.650.520.92-0.770.470.65-0.460.820.860.130.940.470.920.470.87
0.960.490.320.970.46-0.060.670.280.540.870.640.550.93-0.750.450.66-0.410.80.890.230.920.450.90.380.86
0.650.730.840.480.460.820.93-0.48-0.020.740.90.00.55-0.860.980.87-0.950.790.28-0.320.661.00.70.570.67
0.20.530.77-0.01-0.060.820.6-0.72-0.470.390.57-0.450.13-0.580.790.53-0.840.48-0.28-0.520.20.820.260.410.3
0.770.760.770.690.670.930.6-0.190.10.810.950.160.72-0.90.890.95-0.90.810.49-0.120.820.930.850.540.75
0.05-0.2-0.430.30.28-0.48-0.72-0.190.34-0.11-0.170.430.140.24-0.48-0.10.47-0.20.40.120.11-0.490.07-0.22-0.06
0.43-0.22-0.040.480.54-0.02-0.470.10.340.20.170.960.21-0.030.10.060.240.270.840.140.33-0.030.30.210.31
0.970.680.590.880.870.740.390.81-0.110.20.760.20.93-0.960.710.77-0.740.970.63-0.010.930.730.930.510.94
0.750.670.750.650.640.90.570.95-0.170.170.760.250.66-0.830.90.91-0.820.790.52-0.190.780.90.810.560.77
0.44-0.250.030.520.550.0-0.450.160.430.960.20.250.22-0.050.130.10.190.290.870.050.37-0.010.340.340.37
0.930.670.370.920.930.550.130.720.140.210.930.660.22-0.870.490.74-0.580.830.670.230.930.540.920.340.86
-0.88-0.76-0.71-0.77-0.75-0.86-0.58-0.90.24-0.03-0.96-0.83-0.05-0.87-0.81-0.840.89-0.94-0.480.06-0.89-0.85-0.91-0.53-0.88
0.650.610.850.470.450.980.790.89-0.480.10.710.90.130.49-0.810.8-0.890.810.34-0.40.630.980.670.640.69
0.730.850.710.650.660.870.530.95-0.10.060.770.910.10.74-0.840.8-0.830.720.44-0.050.780.860.80.40.65
-0.61-0.77-0.82-0.46-0.41-0.95-0.84-0.90.470.24-0.74-0.820.19-0.580.89-0.89-0.83-0.76-0.140.25-0.62-0.95-0.67-0.53-0.64
0.940.570.670.820.80.790.480.81-0.20.270.970.790.290.83-0.940.810.72-0.760.64-0.180.880.790.890.640.95
0.810.150.190.860.890.28-0.280.490.40.840.630.520.870.67-0.480.340.44-0.140.640.150.750.260.720.430.72
0.040.11-0.330.130.23-0.32-0.52-0.120.120.14-0.01-0.190.050.230.06-0.4-0.050.25-0.180.150.09-0.320.05-0.41-0.09
0.950.620.510.940.920.660.20.820.110.330.930.780.370.93-0.890.630.78-0.620.880.750.090.651.00.440.89
0.640.730.840.470.451.00.820.93-0.49-0.030.730.9-0.010.54-0.850.980.86-0.950.790.26-0.320.650.690.570.67
0.940.630.550.920.90.70.260.850.070.30.930.810.340.92-0.910.670.8-0.670.890.720.051.00.690.470.91
0.530.090.550.470.380.570.410.54-0.220.210.510.560.340.34-0.530.640.4-0.530.640.43-0.410.440.570.470.63
0.950.470.50.870.860.670.30.75-0.060.310.940.770.370.86-0.880.690.65-0.640.950.72-0.090.890.670.910.63
Click cells to compare fundamentals

Amdocs Account Relationship Matchups

Amdocs fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets6.3B6.5B6.4B6.4B7.4B4.5B
Other Current Liab794.4M851.9M787.1M802.0M922.3M968.4M
Total Current Liabilities1.2B1.3B1.3B1.4B1.6B1.0B
Total Stockholder Equity3.6B3.6B3.5B3.5B4.1B2.8B
Property Plant And Equipment Net903.4M931.9M971.2M951.9M1.1B1.1B
Net Debt50.0M172.1M253.5M287.2M258.5M271.4M
Retained Earnings5.3B5.9B6.2B6.5B7.5B7.9B
Accounts Payable110.1M121.2M134.4M293.3M337.3M394.9M
Cash983.2M709.1M573.4M520.1M598.1M720.1M
Non Current Assets Total4.3B4.4B4.4B4.5B5.2B2.6B
Non Currrent Assets Other488.6M630.7M574.9M631.6M726.3M762.6M
Cash And Short Term Investments983.9M965.6M818.0M742.5M853.9M1.0B
Net Receivables861.0M866.8M946.8M944.5M1.1B618.6M
Common Stock Shares Outstanding133.2M128.0M121.9M118.5M106.6M144.3M
Liabilities And Stockholders Equity6.3B6.5B6.4B6.4B7.4B4.5B
Non Current Liabilities Total1.5B1.6B1.6B1.5B1.7B1.8B
Other Current Assets229.6M235.1M238.4M224.6M258.3M307.0M
Other Stockholder Equity(1.7B)(2.3B)(2.6B)(3.0B)(2.7B)(2.5B)
Total Liab2.7B2.9B2.8B2.9B3.3B1.7B
Total Current Assets2.1B2.1B2.0B1.9B2.2B1.9B
Short Term Debt159.1M58.7M43.3M40.0M46.0M43.7M
Property Plant And Equipment Gross903.4M931.9M971.2M951.9M1.1B1.1B
Accumulated Other Comprehensive Income11.7M9.3M(72.5M)(53.3M)(47.9M)(45.5M)
Common Stock4.5M4.5M4.5M4.6M5.3M4.4M
Current Deferred Revenue126.8M237.4M253.7M170.6M196.2M184.3M
Other Liab542.4M586.2M750.3M793.9M913.0M469.4M
Other Assets423.9M488.6M630.7M574.9M661.2M386.6M
Good Will2.6B2.6B2.7B2.7B3.2B1.9B
Intangible Assets296.3M259.0M178.3M181.5M163.4M317.6M
Property Plant Equipment354.0M723.6M931.9M971.2M1.1B1.2B
Short Term Investments752K256.5M244.6M222.5M200.2M266.3M
Net Tangible Assets660.6M567.8M711.0M676.6M609.0M676.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Amdocs Stock Analysis

When running Amdocs' price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.